Lifecore Biomedical, Inc.
LFCR· Nasdaq
LFCRLifecore Biomedical, Inc.
Filed Apr 4, 2013 · 10-Q · 39 days after period end · 0001437749-13-004017
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Revenue | $117.87M | $80.06M | $73.51M |
| Net Income | $4.79M | $4.77M | $2.30M |
| EPS Diluted | $0.18 | $0.18 | $0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
ended Feb 24, 2013 · filed Apr 4, 2013 · 39 d after period end
